Campus Highlights: UC San Francisco
- Effective July 1, 1996, UCSF’s newly established Office of Technology
Management (OTM) assumed responsibility for managing the majority of new
campus inventions. However, most inventions disclosed prior to the effective
date remain in OTT’s portfolio, and OTT continues to receive new disclosures
when multiple UC campuses are involved or the technology is closely related
to one already administered by OTT.
- The number of newly disclosed UCSF inventions to be managed by OTT
dropped by about 50% from FY96 to FY97. Overall patent activity and licensing
remained relatively stable over this period.
- The University’s “Top 25” inventions in FY97 included eight from the
OTT-managed portfolio (see page 13). Two inventions accounted for over
80% of UCSF’s income and virtually all of income growth: Hepatitis-B Vaccine
earned $26.4 million and Process for Splicing Genes, managed by joint holder
Stanford, generated $14.9 million for UC in FY97.
- Most of the $2.6 million drop in net legal expenses for the OTT-managed
portfolio resulted from declines in activity for ongoing infringement actions
involving Insulin and Human Growth Hormone. The majority of legal defense
expenses were incurred for ongoing actions involving the MRI portfolio.
Most patent interference expenses related to the Hepatitis-B Vaccine.
- The $2.8 million increase in inventor share payments from FY96 to FY97
reflected a $5.6 million increase in income from FY95 to FY96. The increase
in State share was related to FY97 income growth. UCSF’s allocation of
OTT operating expenses decreased by $200,000 due largely to a change in
the method used to allocate OTT expenses to the campuses.
- During FY97 the newly formed OTM hired staff and established an infrastructure
to support campus-based activity. By the end of FY97, the office was managing
108 inventions including 83 new disclosures and 25 that were transferred
from the OTT portfolio. The office initiated 18 first patent filings and
entered into nine new license agreements.
- In its first year of operation, OTM generated $65,000 in FY97 licensing
income. Some of the patent expenses that contributed to net legal expenses
of $188,000 are likely to be recovered by future reimbursements from licensees.
The State share appears as a credit because FY97 net legal expenses exceeded
income. Operating expenses for technology transfer-related activities of
OTM were $190,000.
- Taken together, these factors resulted in a 20% ($2.6 million) increase
in net income for the OTT-managed portfolio. UCSF also received interest
earnings from this portfolio totaling $297,000, bringing the net campus
distribution to more than $16 million. Net loss for the OTM-managed portfolio
- In addition to the activity reported above, OTM maintained an active
copyright program with activity summarized below.
Back / Next / Home
/ OTT Home